GlaxoSmithKline drug-discovery competition winners aim to find a new cancer therapy and a novel way to regulate male fertility, projects spearheaded by scientists at the UNC School of Medicine.
The five-year grant recognizes the nation’s most innovative young scientists.
The three-year contract is funded by the Patient-Centered Outcomes Research Institute (PCORI).
Walking program reduces joint stiffness in older breast cancer survivors on aromatase inhibitor therapy
After six weeks of walking, the mean joint pain scores among the participants decreased by 10 percent, fatigue decreased by 19 percent, and joint stiffness decreased by 32 percent.
The Breast Cancer Research Foundation continues its longstanding support of research at UNC Lineberger with $960,000 in awards to four researchers working to discover the causes and find better treatments for breast cancer.
Help her reach her 2,000-hat goal by December 16.
In the editorial, "Misperceptions on electronic health records" published in the News & Observer, Lawrence Marks, MD, Chair of Department of Radiation Oncology and UNC Lineberger member explains on the benefits and drawbacks of electronic health records.
UNC clinical geneticists Jonathan Berg and James Evans spearhead an ambitious project to catalog all genetic variations implicated in disease.
The UNC Lineberger-sponsored conference featured several UNC-affiliated faculty and graduates.
In the article, "Do you want to know what will kill you?" at Salon.com, Jim Evans MD, PhD, Director of Clinical Cancer Genetics and UNC Lineberger member discusses the pros and cons of consumer-marketed genetic testing.